Company page

Contineum Therapeutics, Inc.

Contineum Therapeutics, Inc. (CTNM) is a public company based in the United States with a market capitalization of approximately $532 million. The company focuses on developing innovative therapeutic solutions. As a publicly traded entity, CTNM is listed on the American stock market, providing investors with opportunities to engage in its growth and development.